These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17105215)

  • 1. Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
    Temming K; Meyer DL; Zabinski R; Dijkers EC; Poelstra K; Molema G; Kok RJ
    Bioconjug Chem; 2006; 17(6):1385-94. PubMed ID: 17105215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology.
    Temming K; Lacombe M; van der Hoeven P; Prakash J; Gonzalo T; Dijkers EC; Orfi L; Kéri G; Poelstra K; Molema G; Kok RJ
    Bioconjug Chem; 2006; 17(5):1246-55. PubMed ID: 16984135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative.
    Temming K; Meyer DL; Zabinski R; Senter PD; Poelstra K; Molema G; Kok RJ
    Mol Pharm; 2007; 4(5):686-94. PubMed ID: 17683157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2-targeted antibody drug conjugates for ovarian cancer therapy.
    Jiang J; Dong L; Wang L; Wang L; Zhang J; Chen F; Zhang X; Huang M; Li S; Ma W; Xu Q; Huang C; Fang J; Wang C
    Eur J Pharm Sci; 2016 Oct; 93():274-86. PubMed ID: 27509865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD Peptidomimetic MMAE-Conjugate Addressing Integrin αVβ3-Expressing Cells with High Targeting Index.
    Paulus J; Nachtigall B; Meyer P; Sewald N
    Chemistry; 2023 Feb; 29(12):e202203476. PubMed ID: 36454662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductively cleavable polymer-drug conjugates based on dendritic polyglycerol sulfate and monomethyl auristatin E as anticancer drugs.
    Rades N; Achazi K; Qiu M; Deng C; Haag R; Zhong Z; Licha K
    J Control Release; 2019 Apr; 300():13-21. PubMed ID: 30794827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3.
    Ryppa C; Mann-Steinberg H; Biniossek ML; Satchi-Fainaro R; Kratz F
    Int J Pharm; 2009 Feb; 368(1-2):89-97. PubMed ID: 18992308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy.
    Szlachcic A; Zakrzewska M; Lobocki M; Jakimowicz P; Otlewski J
    Drug Des Devel Ther; 2016; 10():2547-60. PubMed ID: 27563235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
    Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
    Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
    Burns KE; Robinson MK; Thévenin D
    Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic RGD-Peptide-Functionalized Polylipopeptide Micelles for Enhanced Loading and Targeted Delivery of Monomethyl Auristatin E.
    Qiu M; Wang X; Sun H; Zhang J; Deng C; Zhong Z
    Mol Pharm; 2018 Nov; 15(11):4854-4861. PubMed ID: 30259747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3.
    Ryppa C; Mann-Steinberg H; Fichtner I; Weber H; Satchi-Fainaro R; Biniossek ML; Kratz F
    Bioconjug Chem; 2008 Jul; 19(7):1414-22. PubMed ID: 18578486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing Multistep Delivery of PEGylated Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand-Toxin Conjugates for Improved Antitumor Activities.
    Wei X; Yang X; Zhao W; Xu Y; Pan L; Chen S
    Bioconjug Chem; 2017 Aug; 28(8):2180-2189. PubMed ID: 28697305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin α
    Paulus J; Sewald N
    Front Chem; 2022; 10():869639. PubMed ID: 35480387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
    Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
    Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature.
    Mukhopadhyay S; Barnés CM; Haskel A; Short SM; Barnes KR; Lippard SJ
    Bioconjug Chem; 2008 Jan; 19(1):39-49. PubMed ID: 17845003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin α
    Raposo Moreira Dias A; Bodero L; Martins A; Arosio D; Gazzola S; Belvisi L; Pignataro L; Steinkühler C; Dal Corso A; Gennari C; Piarulli U
    ChemMedChem; 2019 May; 14(9):938-942. PubMed ID: 30840356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate.
    Sanderson RJ; Hering MA; James SF; Sun MM; Doronina SO; Siadak AW; Senter PD; Wahl AF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):843-52. PubMed ID: 15701875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.